✦ LIBER ✦
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trials
✍ Scribed by Caseiro, Marcos M.; Nelson, Mark; Diaz, Ricardo S.; Gathe, Joseph; de Andrade Neto, Jose L.; Slim, Jihad; Solano, Antonio; Netto, Eduardo M.; Mak, Carmen; Shen, Junwa; Greaves, Wayne; Dunkle, Lisa M.; Vilchez, Regis A.; Zeinecker, Jennifer
- Book ID
- 119298804
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 929 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0163-4453
No coin nor oath required. For personal study only.